Clinical Trial Update: Empagliflozin and Atrial Fibrillation Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update involving empagliflozin for atrial fibrillation treatment in patients with heart failure, obesity, and diabetes mellitus; curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Diabetes Mellitus
• Heart Failure
• Obesity

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Miulli General Hospital | Conditions: Atrial Fibrillation, Heart Failure | Phase 4 | Status: UNKNOWN